TAIEquity · Weekly research terminal

3164

GenMont Biotech Incorporation

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
16.40 TWD
Fair value
19.50 TWD
Next-week expectancy
Negative 41.66%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

3164

GenMont Biotech Incorporation

Healthcare Biotechnology

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
1,376,165,888
Fair value reference
19.50
Next-week expectancy
Negative · 41.66%

Over the latest 12 completed weeks ending 2026-08-07, 3164 fell 2.38%, moving from 16.80 to 16.40. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -32.78 and has improved across the 12-week window. Market Dynamics is -0.80 on the latest week. Next-week expectancy is negative at 41.66% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
16.40
12-Week Change
-2.38%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.66%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
16.40
12-Week Change
-2.38%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.66%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-32.78
Market Dynamics
-0.80

Over the latest 12 completed weeks ending 2026-08-07, 3164 fell 2.38%, moving from 16.80 to 16.40. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -32.78 and has improved across the 12-week window. Market Dynamics is -0.80 on the latest week. Next-week expectancy is negative at 41.66% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6949 Pell Bio-Med Technology Co., Ltd. TAI 7 Aug 2026 800.00 999.00 799.00 943.00 17.88%
1762 Chunghwa Chemical Synthesis & Biotech Co., Ltd. TAI 7 Aug 2026 32.20 35.75 31.60 35.75 11.02%
6589 EirGenix Inc. TAI 7 Aug 2026 44.60 48.90 44.30 48.20 8.07%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6919 CALIWAY BIOPHARMACEUTICALS CO L TAI 7 Aug 2026 102.00 111.00 102.00 105.00 2.94%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
1733 Apex Biotechnology Corp. TAI 7 Aug 2026 31.30 33.10 30.80 32.00 2.24%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context